Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC-Reference-Cited by-同舟云学术

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC

Published:2024-01 Issue: Volume:39 Page:101818
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

De Marchi Pedro^ORCID,Leal Leticia Ferro,da Silva Luciane Sussuchi^ORCID,Cavagna Rodrigo de Oliveira^ORCID,da Silva Flavio Augusto Ferreira,da Silva Vinicius Duval^ORCID,da Silva Eduardo CA^ORCID,Saito Augusto O.,de Lima Vladmir C. Cordeiro^ORCID,Reis Rui Manuel^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Immunotherapy: a new era in small-cell lung cancer;Goetze;Lancet,2019

2. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review;Wagner;Oncoimmunology,2020

3. Recognizing prognostic and predictive biomarkers in the treatment of non-small cell lung cancer (NSCLC) with immune checkpoint inhibitors (ICIs);Giustini;Lung Cancer (Auckl),2021

4. Pembrolizumab versus chemotherapy for PD-l1-positive non-small-cell lung cancer;Reck;N Engl. J. Med.,2016

5. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;Rittmeyer;Lancet,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer;Translational Oncology;2024-09

2. Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center;Current Oncology;2024-02-19

3. Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer;Frontiers in Immunology;2023-12-07